The Cardiotonic Steroid Marinobufagenin Is a Predictor of Increased Left Ventricular Mass in Obesity: The African-PREDICT Study

The endogenous Na(+)/K(+)-ATPase inhibitor, marinobufagenin (MBG), strongly associates with salt intake and a greater left ventricular mass index (LVMi) in humans and was shown to promote cardiac fibrosis and hypertrophy in animals. The adverse effects of MBG on cardiac remodeling may be exacerbated...

Descripción completa

Detalles Bibliográficos
Autores principales: Strauss-Kruger, Michél, Kruger, Ruan, Smith, Wayne, Gafane-Matemane, Lebo F., Mokwatsi, Gontse, Wei, Wen, Fedorova, Olga V., Schutte, Aletta E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603247/
https://www.ncbi.nlm.nih.gov/pubmed/33081045
http://dx.doi.org/10.3390/nu12103185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603247/
https://www.ncbi.nlm.nih.gov/pubmed/33081045
http://dx.doi.org/10.3390/nu12103185

Ejemplares similares